legionella and public health
play

Legionella and Public Health Natalia Kozak-Muiznieks, PhD Microbiologist Centers for Disease Control and Prevention Division of Bacterial Diseases May 18, 2015 National Center for Immunization & Respiratory Diseases Division of Bacterial

0 downloads 6 Views 2,2 MB Size Report
  1. Legionella and Public Health Natalia Kozak-Muiznieks, PhD Microbiologist Centers for Disease Control and Prevention Division of Bacterial Diseases May 18, 2015 National Center for Immunization & Respiratory Diseases Division of Bacterial Diseases

  2. Legionella Holland/Özel , Robert Koch-Institut

  3. Temperature range of Legionella 35 42 45 55 25 Celsius Fahrenheit 77 95 108 113 131 Dormant Death Growth

  4. Legionella are biofilm associated free-floating bacteria secreted slime surface biofilm-associated bacteria

  5. Disease Transmission Water Supplies Host Amplification Aerosolization Transmission

  6. Incidence of Legionellosis — United States, 1998-2011* 1.6 Incidence per 100,000 pop. 1.4 1.2 1 0.8 0.6 0.4 0.2 0 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 Year • *National Notifiable Disease Surveillance System • 2013: provisional report until Sept 2013

  7. Average Annual Rates of Reported Legionellosis Cases per 100,000 Population, NNDSS, 2000-2009 < 0.50 0.50 - 1.00 1.01 - 1.50 1.51 - 2.00 2.01 - 2.50 2.51 - 3.00 Note: Alaska and Hawaii are part of the Pacific Reporting Area

  8. What is an outbreak?  An outbreak is 2+ cases within 1 year  Exception: hospitals 1 confirmed case or 2 suspect  Responses:  Consultation  Collaboration  Epi-Aid

  9. Epidemiology  Patient Questionnaires  Case definition  Case finding  Initial recommendations

  10. What is the source? 6 4 5 3 Number of cases 4 Case Count 3 2 2 1 1 0 8/31/2013 9/30/2013 0 Symptom Onset Date Illness onset

  11. Legionella Environmental Assessment  Facility characteristics  Outside water supply  Premise plumbing system  Hot tubs and whirlpool spas  Cooling towers  Recent or ongoing major constructions

  12. Commonly Sampled Locations  Central distribution point (hot water heater)  Rooms where patients were housed (potable)  Aerosol generating devices (cooling towers, humidifiers, etc.)  Medical devices (hydrotherapy pools, CPAP machines, etc.)  Recreational and decorative features (whirlpool spas, fountains, etc.)

  13. Sample Processing, Legionella Isolation and Characterization 5-8 hours - Initial sample processing Up to 7 days - Incubation Up to 2 days - Confirming Legionella isolates to genus level • 3- 4 days - Getting single colony isolates • Up to 2 weeks - Identification species, serogroups and genotypes BCYE BCYE without L-cysteine

  14. Genus Legionella 60 species of Legionellae > 90% of the isolates associated with 17 serogroups of Legionnaires’ disease - L. pneumophila L. pneumophila 79% of cases are due to L. Lp6, Lp5, Lp8 are also pneumophila serogroup 1 (Lp1) frequent “offenders” majority of Lp1 clinical MAb panel contains 7 isolates reacts with monoclonal MAb2 antibodies Virulent genotypes There are > 2000 sequence types of L. pneumophila, yet only 16 STs are responsible for the majority of sporadic LD cases

  15. Recommendations and Conclusions • Water restrictions • Notify residents • Begin (or continue) active surveillance • Emergency remediation (heat flush and/or hyperchlorination) • Post remediation sampling 2X monthly for 3 months • Post remediation sampling 1X monthly for additional 3 months • Strive for eradication

  16. Knowledge Gaps • Better methods of acute remediation • Best methods for long term control – situational? • How to evaluate emerging technologies? • Safe level of Legionella ?

  17. Case Studies

  18. VA Hospital  Background:  High rate LD testing  Routine environmental testing  Cu/Ag disinfection  Investigation  Aug: 2 clinical isolates  Oct: 1 environmental isolate  Since 2010: 5 confirmed, 21 suspect  Similar to 1982 environmental  Conclusions:  Long term persistence  Low suspicion

  19. Las Vegas Condominiums  Background:  2001: 3 travel cases  2002: chlorine dioxide  2008: 4 travel cases  Investigation  16 confirmed, 19 probable  Transmission through showers  ST35 in 2001, 2002, & 2008  ST35: one of the “bad” STs  Conclusions:  Long term persistence  Increase temp & ClO 2 • Silk BJ et al. Epidemiol Infect. 2012 Nov;140(11):1993-2002. Epub 2012 Jan 4.

  20. GA Resort  Background:  2007 – 2014 six LD cases  Stayed in 6 different rooms or chalets  Investigation:  Water supplied by 5 wells w/out disinfectant or filtration  Outdoor spas inside rooms  Staff couldn’t describe water system in reasonable details  35% sites positive for Lp1 ST36  Conclusion:  Importance of residual disinfection

  21. Thank you! Natalia Kozak-Muiznieks Centers for Disease Control and Prevention 1600 Clifton Rd NE MS G03 Atlanta, GA 30333 Phone (404) 639-2305 For more information please contact Centers for Disease Control and Prevention 1600 Clifton Road NE, Atlanta, GA 30333 Telephone, 1-800-CDC-INFO (232-4636)/TTY: 1-888-232-6348 E-mail: cdcinfo@cdc.gov Web: www.cdc.gov The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. National Center for Immunization & Respiratory Diseases Division of Bacterial Diseases

Recommend Documents


pneumophila softly killing legionella pneumophila
pneumophila softly Killing Legionella

Killing Legionella pneumophila softly Killing Legionella pneumophila Killing

part ii
Part II Legionella biology Explaining

Part II Legionella biology Explaining building colonization and disease

overview of control of
Overview of Control of Legionella in

Health and Safety Executive Overview of Control of Legionella in hot and

the dot icm type iv secretion system and effector
The Dot/Icm Type IV secretion system

The Dot/Icm Type IV secretion system and effector proteins: essential players

hbe risk management
HBE Risk Management Peter Fitzpatrick

HBE Risk Management Peter Fitzpatrick (Health & Safety Manager) &

legionella
Legionella Stagnant water Bacteria

The Control of Legionella Bacteria in Water Systems COVID 19 28 th of May

commissioned health care buildings
commissioned health care buildings

Legionella detections in newly commissioned health care buildings Greg Crisp

legio guard
Legio Guard Excellence in Legionella

Legio Guard Excellence in Legionella Control Summary LegioGuard have

orientation to public health for students
Orientation to Public Health for

Orientation to Public Health for Students September 2011 Welcome to Public

cdc public health grand rounds
CDC PUBLIC HEALTH GRAND ROUNDS Public

CDC PUBLIC HEALTH GRAND ROUNDS Public Health Law: A A Tool to Address

current human illness surveillance systems
Current Human Illness Surveillance

Current Human Illness Surveillance Systems Apps and Gaps Patricia M. Griffin,

when we talk about patient engagement and shared decision
When we talk about patient engagement

When we talk about patient engagement and shared decision-making there are a

surveillance tools and methods including field
Surveillance tools and methods

Felix Njeumi, FAO Susanne Mnstermann, OIE Members of the PPR working group

marijuana and cdphe
Marijuana and CDPHE Tista Ghosh, MD,

Marijuana and CDPHE Tista Ghosh, MD, MPH Deputy Chief Medical Officer CDPHEs

ne vada ove r dose data to ac tion sur ve illanc e
Ne vada Ove r dose Data to Ac tion

Ne vada Ove r dose Data to Ac tion Sur ve illanc e Compone nt Re vie w

robbert zusterzeel md phd mph
Robbert Zusterzeel, MD, PhD, MPH

Robbert Zusterzeel, MD, PhD, MPH Director (Data Network) RAPID Meeting -

safety of third trimester immunization with a respiratory
Safety of Third Trimester Immunization

Safety of Third Trimester Immunization with a Respiratory Syncytial Virus

disease surveillance
DISEASE SURVEILLANCE & CONTROL

DISEASE SURVEILLANCE & CONTROL LOCAL PUBLIC HEALTH PERSPECTIVE Barbara

multi drug resistant organisms mdros in healthcare
Multi-drug Resistant Organisms (MDROs)

Multi-drug Resistant Organisms (MDROs) in Healthcare Facilities Gail Bennett

clabsi update
CLABSI Update How to Succeed with a

3/30/2016 CLABSI Update How to Succeed with a Moving Target Joan M. Ivaska,

centers for medicare amp
Centers for Medicare & Medicaid

Centers for Medicare & Medicaid Services Inpatient Rehabilitation

of enforcement under the ccpsa
of Enforcement Under the CCPSA

Chemicals Management Plan: An Overview of Enforcement Under the CCPSA